Proposed mechanism of cerebral vasospasm: Our hypothesis and current topics

Acta Neurochirurgica, Supplementum

Volumn 115, Issue , 2013, Pages 53-56

  Sasaki, Tomio ^a   Kikkawa, Yuichiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Cerebral vasospasm; Endothelium; Subarachnoid hemorrhage; Vascular contractility; Vascular smooth muscle

Indexed keywords

CALCIUM; CLAZOSENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; G PROTEIN COUPLED RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE; OXYHEMOGLOBIN; PERHYDRO 1 AZEPINYLCARBONYLLEUCYL DEXTRO TRYPTOPHYL DEXTRO TRYPTOPHAN; PHENYLEPHRINE; PLACEBO; PRAVASTATIN; SIMVASTATIN; THROMBIN;

BASILAR ARTERY; BRAIN ISCHEMIA; BRAIN VASOSPASM; CONFERENCE PAPER; CORTICAL SPREADING DEPOLARIZATION; DELAYED ISCHEMIC NEUROLOGICAL DEFICIT; DEPOLARIZATION; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; FEEDBACK SYSTEM; HUMAN; HYPOTHESIS; MYOFILAMENT; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; RISK REDUCTION; SUBARACHNOID HEMORRHAGE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

EID: 85052609062     PISSN: 00651419     EISSN: 00016268     Source Type: Book Series    
DOI: 10.1007/978-3-7091-1192-5_12     Document Type: Conference Paper

References (25)

1. Chou SH, Smith EE, Badjatia N, Nogueira RG, Sims JR 2nd, Ogilvy CS, Rordorf GA, Ayata C (2008) A randomized, doubleblind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke 39:2891-28933
2. Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407:258-2644
3. Dreier JP (2011) The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med 17:439-4477
4. Dreier JP, Ebert N, Priller J, Megow D, Lindauer U, Klee R, Reuter U, Imai Y, Einhaupl KM, Victorov I, Dirnagl U (2000) Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: A model for delayed ischemic neurological de fi cits after subarachnoid hemorrhage? J Neurosurg 93:658-6666
5. Dreier JP, Kleeberg J, Petzold G, Priller J, Windmuller O, Orzechowski HD, Lindauer U, Heinemann U, Einhaupl KM, Dirnagl U (2002) Endothelin-1 potently induces Leao's cortical spreading depression in vivo in the rat: A model for an endothelial trigger of migrainous aura? Brain 125:102-1122
6. Dreier JP, Woitzik J, Fabricius M, Bhatia R, Major S, Drenckhahn C, Lehmann TN, Sarrafzadeh A, Willumsen L, Hartings JA, Sakowitz OW, Seemann JH, Thieme A, Lauritzen M, Strong AJ (2006) Delayed ischaemic neurological de fi cits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 129:3224-32377
7. Ide K, Yamakawa K, Nakagomi T, Sasaki T, Saito I, Kurihara H, Yosizumi M, Yazaki Y, Takakura K (1989) The role of endothelin in the pathogenesis of vasospasm following subarachnoid haemorrhage. Neurol Res 11:101-1044
8. Itoh S, Sasaki T, Ide K, Ishikawa K, Nishikibe M, Yano M (1993) A novel endothelin ET A receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs. Biochem Biophys Res Commun 195:969-9755
9. Kai Y, Hirano K, Maeda Y, Nishimura J, Sasaki T, Kanaide H (2007) Prevention of the hypercontractile response to thrombin by proteinase-activated receptor-1 antagonist in subarachnoid hemorrhage. Stroke 38:3259-32655
10. Kikkawa Y, Kameda K, Hirano M, Sasaki T, Hirano K (2010) Impaired feedback regulation of the receptor activity and the myo fi lament Ca 2+ sensitivity contributes to increased vascular reactiveness after subarachnoid hemorrhage. J Cereb Blood Flow Metab 30:1637-16500
11. Lynch JR, Wang H, McGirt MJ, Floyd J, Friedman AH, Coon AL, Blessing R, Alexander MJ, Graffagnino C, Warner DS, Laskowitz DT (2005) Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: Results of a pilot randomized clinical trial. Stroke 36:2024-20266
12. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N (2011) Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: A randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 10:618-6255
13. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A (2008) Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): Randomized, doubleblind, placebo-controlled phase 2 dose- fi nding trial. Stroke 39:3015-30211
14. Maeda Y, Hirano K, Kai Y, Hirano M, Suzuki SO, Sasaki T, Kanaide H (2007) Up-regulation of proteinase-activated receptor 1 and increased contractile responses to thrombin after subarachnoid haemorrhage. Br J Pharmacol 152:1131-11399
15. Moncada S, Gryglewski R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663-6655
16. Moncada S, Korbut R, Bunting S, Vane JR (1978) Prostacyclin is a circulating hormone. Nature 273:767-7688
17. Nakagomi T, Ide K, Yamakawa K, Sasaki T, Kurihara H, Saito I, Takakura K (1989) Pharmacological effect of endothelin, an endothelium-derived vasoconstrictive peptide, on canine basilar arteries. Neurol Med Chir (Tokyo) 29:967-9744
18. Nakagomi T, Kassell NF, Sasaki T, Fujiwara S, Lehman RM, Torner JC (1987) Impairment of endothelium-dependent vasodilation induced by acetylcholine and adenosine triphosphate following experimental subarachnoid hemorrhage. Stroke 18: 482-489
19. Nakayama T, Hirano K, Shintani Y, Nishimura J, Nakatsuka A, Kuga H, Takahashi S, Kanaide H (2003) Unproductive cleavage and the inactivation of protease-activated receptor-1 by trypsin in vascular endothelial cells. Br J Pharmacol 138:121-1300
20. Petzold GC, Einhaupl KM, Dirnagl U, Dreier JP (2003) Ischemia triggered by spreading neuronal activation is induced by endothelin-1 and hemoglobin in the subarachnoid space. Ann Neurol 54:591-5988
21. Sasaki T, Kassell NF, Yamashita M, Fujiwara S, Zuccarello M (1985) Barrier disruption in the major cerebral arteries following experimental subarachnoid hemorrhage. J Neurosurg 63: 433-440
22. Sasaki T, Murota SI, Wakai S, Asano T, Sano K (1981) Evaluation of prostaglandin biosynthetic activity in canine basilar artery following subarachnoid injection of blood. J Neurosurg 55: 771-778
23. Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ (2005) Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic de fi cits after aneurysmal subarachnoid hemorrhage: A phase II randomized placebo-controlled trial. Stroke 36:1627-16322
24. Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, Breu V, Schmiedek P (2005) Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: Results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg 103:9-177
25. Vergouwen MD, Meijers JC, Geskus RB, Coert BA, Horn J, Stroes ES, van der Poll T, Vermeulen M, Roos YB (2009) Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: A double-blind, placebo-controlled randomized trial. J Cereb Blood Flow Metab 29:1444-14533